Latest Insider Transactions at Reviv3 Procare CO (RVIV)
This section provides a real-time view of insider transactions for Reviv3 Procare CO (RVIV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Reviv3 Procare Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Reviv3 Procare Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Manu Ohri Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Feb 14
2024
|
Peter Philip Dunne Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+16.0%
|
-
|
|
Feb 14
2024
|
Nancy Hundt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+40.74%
|
-
|
|
Oct 18
2023
|
Jeff Toghraie Chairman, CEO |
BUY
Open market or private purchase
|
Indirect |
2,100,000
+7.77%
|
$0
$0.12 P/Share
|
|
Oct 18
2023
|
Nancy Hundt Director |
SELL
Open market or private sale
|
Direct |
2,100,000
-97.88%
|
$0
$0.12 P/Share
|
|
Apr 10
2023
|
Jeff Toghraie Chairman, CEO |
BUY
Other acquisition or disposition
|
Indirect |
15,000,000
+39.39%
|
-
|
|
Feb 10
2023
|
Jeffrey B. Brown CFO, COO |
SELL
Open market or private sale
|
Direct |
2,500
-0.82%
|
$0
$0.42 P/Share
|
|
Feb 08
2023
|
Jeffrey B. Brown CFO, COO |
SELL
Open market or private sale
|
Direct |
2,655
-0.43%
|
$0
$0.46 P/Share
|
|
Jan 30
2023
|
Jeffrey B. Brown CFO, COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.32%
|
$0
$0.29 P/Share
|